PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Public ClinicalTrials.gov record NCT03970538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: the PROMISE II Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The LimFlow System is intended for endovascular, minimally invasive procedures in patients who have a clinical diagnosis of chronic limb-threatening ischemia and who have been determined to have no surgical or endovascular treatment option (i.e., "no option").
Study identification
- NCT ID
- NCT03970538
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 6, 2019 (Actual)
- Primary completion
- Sep 9, 2022 (Actual)
- Completion
- Feb 28, 2025 (Estimated)
- Last update posted
- Feb 28, 2024
2019 – 2025
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94143 | — |
| Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| The Cardiac and Vascular Institute | Gainesville | Florida | 32605 | — |
| University of Florida | Gainesville | Florida | 32608 | — |
| Unitypoint Health | Des Moines | Iowa | 50309 | — |
| Ochsner Health System | Kenner | Louisiana | 70065 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| Saint Luke's Hospital | Lee's Summit | Missouri | 64086 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | — |
| New Mexico Heart Institute | Albuquerque | New Mexico | 87102 | — |
| Atrium Health | Charlotte | North Carolina | 28203 | — |
| Coastal Carolina Surgical Associates | Wilmington | North Carolina | 28401 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Prisma Health -- Midlands | Columbia | South Carolina | 29203 | — |
| Prisma Health -- Upstate | Greenville | South Carolina | 29615 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Seton Heart | Austin | Texas | 78723 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03970538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2024 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03970538 live on ClinicalTrials.gov.